Cargando…
Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is correlated with worse clinical prognosis and lacks available targeted therapy. Thus, identification of reliable biomarkers is required for the diagnosis and treatment of ESCC. METHODS: We downloaded the GSE53625 dataset as a training dataset t...
Autores principales: | Zhang, Jinfeng, Ling, Xiaodong, Fang, Chengyuan, Ma, Jianqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109328/ https://www.ncbi.nlm.nih.gov/pubmed/35578166 http://dx.doi.org/10.1186/s11658-022-00331-x |
Ejemplares similares
-
Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma
por: Zheng, Ze-Jun, et al.
Publicado: (2022) -
Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022) -
Immune‐related eight‐lncRNA signature for improving prognosis prediction of lung adenocarcinoma
por: Chen, Yan, et al.
Publicado: (2021) -
Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma
por: Wang, Jian, et al.
Publicado: (2021) -
An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma
por: Gong, Zhenyu, et al.
Publicado: (2020)